Kolexia
Boudou-Rouquette Pascaline
Oncologie médicale
Hôpital Cochin
Paris, France
224 Activités
156 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Ostéosarcome Sarcopénie Tumeurs osseuses Récidive tumorale locale

Industries

Pfizer
4 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2022
MSD
2 collaboration(s)
Dernière en 2022
Pharma Mar
2 collaboration(s)
Dernière en 2023

Dernières activités

CHIC-STS01: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   26 février 2024
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
Comparison of the prognostic value of eight nutrition-related tools in older patients with cancer: A prospective study.
The journal of nutrition, health & aging   12 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European journal of cancer (Oxford, England : 1990)   23 novembre 2023
REGOBONE: A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Essai Clinique (Unicancer)   06 novembre 2023
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
British journal of cancer   01 novembre 2023
MIRAS: Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   22 septembre 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.
Journal of translational medicine   19 septembre 2023
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
Cancer treatment reviews   15 septembre 2023